ASTI — Aquarius Surgical Technologies Income Statement
0.000.00%
Last trade - 00:00
- CA$1.10m
- CA$4.87m
- CA$0.20m
- 14
- 21
- 41
- 15
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.393 | 0.959 | 0.583 | 0.328 | 0.204 |
Cost of Revenue | |||||
Gross Profit | 0.161 | 0.378 | 0.217 | 0.13 | 0.082 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1.99 | 2.58 | 2.41 | 1.48 | 0.957 |
Operating Profit | -1.6 | -1.63 | -1.83 | -1.15 | -0.753 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.59 | -1.61 | -1.81 | -0.859 | -0.723 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.59 | -1.61 | -1.81 | -0.859 | -0.723 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.59 | -1.61 | -1.81 | -0.859 | -0.723 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.59 | -1.61 | -1.81 | -0.859 | -0.723 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.082 | -0.076 | -0.05 | -0.037 | -0.034 |